Stock Exchanges podcast

Bioventix - Peter Harrison

0:00
36:18
Retroceder 15 segundos
Avanzar 15 segundos

Peter Harrison, Chief Executive of Bioventix PLC, joins Victoria Stevens for the latest episode of Stock Exchanges to discuss building a highly profitable biotechnology business from a management buyout over two decades ago.

Peter explains how he transformed a failing therapeutic antibody company into a diagnostics business, why sheep monoclonal antibodies offer advantages over traditional mouse antibodies for blood tests, and how Bioventix is contributing to research efforts in early Alzheimer's detection through biomarker development.

Otros episodios de "Stock Exchanges"